Urticaria
📧 Sign up to get email alerts when something new happens for Urticaria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-05-23Clinical Trial Update: Glucocorticoids With Antihistamines Versus Antihistamines in Acute Urticaria in Emergency [Phase 2, Phase 3]
A phase 2/3 trial comparing glucocorticoids with antihistamines versus antihistamines alone in acute urticaria has completed.
-
FDA approval · 2023-05-08FDA Approved: ZYRTEC HIVES — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC HIVES (cetirizine hydrochloride) by Kenvue Brands LLC, updating the label to address trea…
-
FDA approval · 2023-04-19FDA Approved: CETIRIZINE HYDROCHLORIDE ORAL SOLUTION — Supplemental Application (APOZEAL PHARMACEUTICALS INC)
FDA approved a supplemental application for cetirizine hydrochloride oral solution by Apozeal Pharmaceuticals, updating the approved labelin…
-
FDA approval · 2023-04-13FDA Approved: ALLERGY RELIEF — Supplemental Application (WALGREENS)
FDA approves Walgreens' supplemental application for an allergy-relief product containing cetirizine hydrochloride (Allergy Relief).
-
FDA approval · 2023-03-24FDA Approved: LORATADINE — Original Application (Aurohealth LLC)
The FDA approved Aurohealth LLC's original application for loratadine, a generic antihistamine. It covers indications for allergic rhinitis …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-12-27FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add a new chewable grape and bubblegum formulation of Claritin (loratadine) from Bayer HealthCare…
-
FDA approval · 2022-12-27FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Children's Allegra Allergy containing fexofenadine hydrochloride, submitted by Chattem, Inc., to…
-
FDA approval · 2022-12-20FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Children's Allegra Allergy (fexofenadine hydrochloride) to support labeling for pediatric use, e…
-
FDA approval · 2022-07-08FDA Approved: ALLERGY RELIEF — Supplemental Application (Publix Super Markets Inc)
FDA approved a supplemental application for Allergy Relief containing fexofenadine hydrochloride, submitted by Publix Super Markets Inc.
-
EMA approval · 2022-06-24EMA Authorised: Desloratadine ratiopharm (desloratadine) — Ratiopharm GmbH
Authorised desloratadine product Desloratadine ratiopharm by Ratiopharm GmbH for allergic rhinitis and urticaria indications.
-
EMA approval · 2022-06-09EMA Authorised: Dasselta (desloratadine) — Krka, d.d., Novo mesto
Dasselta (desloratadine) by Krka has been authorised for allergic rhinitis (perennial and seasonal) and urticaria in the EU.
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Using Doxepin for Urticaria [Phase 3]
Phase 3 trial investigating doxepin for urticaria is in progress with unknown status.
-
FDA approval · 2021-12-14FDA Approved: ZYRTEC — Supplemental Application (Kenvue Brands LLC)
FDA approves a supplemental application for ZYRTEC (cetirizine hydrochloride) submitted by Kenvue Brands LLC.
-
CLINICAL_TRIALS trial_result · 2021-12-03Clinical Trial Update: Modified Xiao-Feng Powder for Chronic Urticaria [Phase 2]
Phase 2 clinical trial update for Modified Xiao-Feng Powder in chronic urticaria.
-
CLINICAL_TRIALS trial_result · 2021-10-14Clinical Trial Update: Assessment of Suppression of Cutaneous Allergic Responses and Pruritus by Topical Doxycycline [Phase 2]
Phase 2 trial assessing suppression of cutaneous allergic responses and pruritus with topical doxycycline for hives.
-
FDA approval · 2021-10-13FDA Approved: ALLEGRA HIVES 24HR — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for Allegra Hives 24HR, a fexofenadine hydrochloride product from Chattem, expanding its labelin…
-
FDA approval · 2021-07-12FDA Approved: PROMETHAZINE HYDROCHLORIDE — Original Application (QUAGEN PHARMACEUTICALS LLC)
FDA approved promethazine hydrochloride under an original ANDA for Quagen Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2021-06-24Clinical Trial Update: Study on the Correlation Between Intestinal Microecology and Allergic Diseases in Children [Phase 4]
Phase 4 trial exploring the relationship between intestinal microecology and allergic diseases in children.
-
FDA approval · 2021-04-02FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add a chewable grape and bubblegum formulation of loratadine (Claritin) by Bayer HealthCare LLC.
-
FDA approval · 2021-03-25FDA Approved: CARBINOXAMINE MALEATE EXTENDED-RELEASE ORAL SUSPENSION — Supplemental Application (Neos Therapeutics, LP)
FDA approved a supplemental application to authorize an extended-release oral suspension formulation of carbinoxamine maleate, submitted by …
-
FDA approval · 2021-01-11FDA Approved: CLARITIN REDITABS — Supplemental Application (Bayer Healthcare LLC.)
FDA approved a supplemental application for CLARITIN REDITABS (loratadine) from Bayer Healthcare LLC., enabling a new or revised indication …
-
FDA approval · 2021-01-07FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application for Claritin Chewable Grape and Bubblegum (loratadine) by Bayer HealthCare LLC, adding a chewabl…
-
FDA approval · 2020-12-07FDA Approved: CETIRIZINE HCL — Supplemental Application (AMERISOURCE BERGEN)
The FDA approved a supplemental application for cetirizine hydrochloride submitted by AmerisourceBergen.
-
CLINICAL_TRIALS trial_result · 2020-12-04Clinical Trial Update: Effect of Omalizumab (Xolair) on Basophils in Patients With Chronic Idiopathic Urticaria [Phase 4]
Phase 4 trial investigating the effect of omalizumab (Xolair) on basophils in patients with chronic idiopathic urticaria.
-
FDA label_change · 2020-11-30FDA Approved: ZYRTEC — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC (cetirizine hydrochloride) to update the product labeling.